Zhao T - Search Results

1

Preablative Stimulated Thyroglobulin Correlates to New Therapy Response System in Differentiated Thyroid Cancer.

Yang X, Liang J, Li T, Zhao T, Lin Y. Yang X, et al. Among authors: zhao t. J Clin Endocrinol Metab. 2016 Mar;101(3):1307-13. doi: 10.1210/jc.2015-4016. Epub 2016 Jan 20. J Clin Endocrinol Metab. 2016. PMID: 26789779

2

Downregulation of SNAIL sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis by regulating the NF-κB pathway.

Wan Z, Pan H, Liu S, Zhu J, Qi W, Fu K, Zhao T, Liang J. Wan Z, et al. Among authors: zhao t. Oncol Rep. 2015 Mar;33(3):1560-6. doi: 10.3892/or.2015.3743. Epub 2015 Jan 20. Oncol Rep. 2015. PMID: 25607597

3

Relationship between Variation of Pre-ablation Stimulated Thyroglobulin and Distant Metastasis in Patients with Differentiated Thyroid Cancer.

Zhao T, Liang J, Li TJ, Li CX, Hui C, Yang K, Li F, Lin YS. Zhao T, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2015 Jun;37(3):315-9. doi: 10.3881/j.issn.1000-503X.2015.03.013. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2015. PMID: 26149144

4

[Effect of Selenious Yeast Tablets on the Thyroglobulin Antibody Level in ThyroglobulinAntibody-positive Patients with Differentiated Thyroid Cancer].

Cong H, Li H, Liang J, Yang K, Zhao T, Qiu WS, Lin YS. Cong H, et al. Among authors: zhao t. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2015 Oct;37(5):591-5. doi: 10.3881/j.issn.1000-503X.2015.05.017. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2015. PMID: 26564513 Chinese.

5

Noninferior response in BRAF(V600E) mutant nonmetastatic papillary thyroid carcinoma to radioiodine therapy.

Li J, Liang J, Zhao T, Lin Y. Li J, et al. Among authors: zhao t. Eur J Nucl Med Mol Imaging. 2016 Jun;43(6):1034-9. doi: 10.1007/s00259-015-3305-1. Epub 2016 Jan 16. Eur J Nucl Med Mol Imaging. 2016. PMID: 26780618

6

Serum thyrotropin level of 30 μIU/mL is inadequate for preablative thyroglobulin to serve as a prognostic marker for differentiated thyroid cancer.

Zhao T, Liang J, Guo Z, Li J, Lin Y. Zhao T, et al. Endocrine. 2016 Jul;53(1):166-73. doi: 10.1007/s12020-015-0842-0. Epub 2016 Jan 18. Endocrine. 2016. PMID: 26782372

7

Value of serial preablative thyroglobulin measurements: can we address the impact of thyroid remnants?

Zhao T, Liang J, Li T, Guo Z, Vinjamuri S, Lin Y. Zhao T, et al. Nucl Med Commun. 2016 Jun;37(6):632-9. doi: 10.1097/MNM.0000000000000485. Nucl Med Commun. 2016. PMID: 26829063

8

In Patients With Low- to Intermediate-Risk Thyroid Cancer, a Preablative Thyrotropin Level of 30 μIU/mL Is Not Adequate to Achieve Better Response to 131I Therapy.

Zhao T, Liang J, Guo Z, Li T, Lin Y. Zhao T, et al. Clin Nucl Med. 2016 Jun;41(6):454-8. doi: 10.1097/RLU.0000000000001167. Clin Nucl Med. 2016. PMID: 26914559

9

Response to (131)I Therapy in Non-metastatic Differentiated Thyroid CancerPatients with Preablative Stimulated Thyroglobulin above 10 ng/ml.

Hou M, Zhao T, Yang X, Li J, Li H, Lin YS. Hou M, et al. Among authors: zhao t. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016 Feb;38(1):83-7. doi: 10.3881/j.issn.1000-503X.2016.01.015. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016. PMID: 26956862

10

Clinical Outcome of (131)I Therapy in Differentiated Thyroid Cancer with Preablative Thyroglobulin below 10 ng/ml.

Liu XF, Li J, Zhao T, Hou M, Li H, Liang J, Lin YS. Liu XF, et al. Among authors: zhao t. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016 Feb;38(1):88-92. doi: 10.3881/j.issn.1000-503X.2016.01.016. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016. PMID: 26956863

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,667 results

Search Page

Filters